KKR and state-backed JIC join forces to take Japan's Topcon private for $2.31 billion
By Anton Bridge and Makiko Yamazaki TOKYO (Reuters) -U.S.-based private equity firm KKR and a unit of Japanese state-backed ...
KKR and JIC take Japan's Topcon private for $2.31 billion
TOKYO (Reuters) -U.S.-based private equity firm KKR and Japanese state-backed fund Japan Investment Corp (JIC) will acquire ...
Topcon to Accelerate Growth through Management Buyout with KKR and JIC Capital
Powerful combination of KKR and JICC creates stable foundations for Topcon to pursue long-term growth. TOKYO, March 28, 2025--(BUSINESS WIRE)--Topcon Corporation ("Topcon" or the ...
Eye Care Company Topcon Goes Private Via Management Buyout Deal At Huge Premium
Topcon launches a management buyout with KKR and JIC Capital, offering 3,300 yen per share. The move supports its long-term ...
M&A News: Japan’s Topcon Heads to the Stars After $2.31B Purchase By Private Equity Giant KKR
Shares in U.S. private equity firm KKR & Co were higher today after it sealed a $2.31 billion deal to buy Japanese medical, agricultural, ...
Simpson Thacher, Nishimura & Asahi Japan Among Advisers on KKR, JIC’s $2.3B Medical Gear Buyout
KKR will invest around $1.7 billion for a majority stake and JIC's private equity arm will invest $635 million for a minority ...
Nikkei Asia6d
KKR and state-backed JIC to take Japan's Topcon private for $2.3bn
TOKYO (Reuters) -- U.S.-based private equity firm KKR and Japanese state-backed fund Japan Investment Corp (JIC) will acquire ...
KKR (NYSE:KKR) Plans US$300 Million Share Sale In JB Chemicals Stake Transaction
KKR (NYSE:KKR) recently announced plans to sell up to $300 million worth of shares in J.B. Chemicals & Pharmaceuticals Limited, representing a potential 10.2% stake in the company. This strategic move ...
Seeking Alpha6d
Topcon to accelerate growth through management buyout with KKR and JIC Capital
In connection with the MBO, TK Co., an entity owned by investment funds managed by KKR, intends to make a tender offer for the common shares and share acquisition rights of the company.